Celldex (CLDX) Tops Q2 EPS by 4c

Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $3.83 million versus the consensus estimate of $1.05 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• Hermès can regain momentum despite China weakness, Jefferies says